ARTICLES BY NANCY BRADISH MYERS
-
FDA User Fee Programs Reauthorized: FDA's CBER Is A Clear Winner10/6/2022
Last minute, squeaky clean! After years of planning, negotiation, and input, the user fee reauthorization bill was passed and signed into law on the very date that the programs were scheduled to sunset. This article sums up the key takeaways, CBER's reorganization with new product-specific offices, and more.